摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-甲基-N-苄氧羰基-L-谷氨酸 5-叔丁酯 | 42417-71-0

中文名称
N-甲基-N-苄氧羰基-L-谷氨酸 5-叔丁酯
中文别名
N-甲基-N-苄氧羰基-L-谷氨酸5-叔丁酯;N-甲基-N-苄氧羰基-L-谷氨酸-5-叔丁酯
英文名称
(S)-2-(((benzyloxy)carbonyl)(methyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid
英文别名
Cbz-N-Me-Glu(OtBu)-OH;(2S)-2-[methyl(phenylmethoxycarbonyl)amino]-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
N-甲基-N-苄氧羰基-L-谷氨酸 5-叔丁酯化学式
CAS
42417-71-0
化学式
C18H25NO6
mdl
——
分子量
351.4
InChiKey
XPZXECGLTZKQDX-AWEZNQCLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    501.0±50.0 °C(Predicted)
  • 密度:
    1.184

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    25
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    93.1
  • 氢给体数:
    1
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2922509090

SDS

SDS:2bd32dd6534ba3a011a4da932997e198
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Z-N-Me-glu(otbu)-oh
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Z-N-Me-glu(otbu)-oh
CAS number: 42417-71-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C18H25NO6
Molecular weight: 351.4

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    N-甲基-N-苄氧羰基-L-谷氨酸 5-叔丁酯氯甲酸乙酯三乙胺 、 sodium tetrahydroborate 作用下, 以 四氢呋喃 为溶剂, 反应 0.34h, 生成 tert-butyl (S)-4-(((benzyloxy)carbonyl)(methyl)amino)-5-hydroxypentanoate
    参考文献:
    名称:
    优化芳霉素抗生素活性的初步努力
    摘要:
    虽然大多数临床使用的抗生素来自天然产物,但新的广谱天然产物的分离变得越来越罕见,而且由于其支架或靶标的内在限制,通常认为窄谱药物不适合开发。然而,天然产物抗生素的谱可能会受到某些细菌特定耐药机制的限制,例如靶点突变,并且这种“潜在”抗生素的谱可能会通过衍生化重新优化,就像之前所做的那样临床部署的抗生素。我们最近展示了 arylomycin 天然产物抗生素的谱系,它们通过抑制 I 型信号肽酶的新机制起作用,比以前认为的更广泛,并且几种关键人类病原体的耐药性是由于目标肽酶中存在特定的 Pro 残基,该残基破坏了与抗生素脂肽尾部的相互作用。为了开始测试这种天然抗性是否可以通过衍生化来克服,我们合成了脂肽尾部改变的类似物,并确定了几种具有增加的抗金黄色葡萄球菌。数据支持了芳霉素是潜在抗生素的假设,表明它们的谱可以通过衍生化进行优化,并确定了未来优化工作可能会关注的有前途的支架。
    DOI:
    10.1021/jm1016126
点击查看最新优质反应信息

文献信息

  • Generation and Cross-Coupling of Organozinc Reagents in Flow
    作者:Ananda Herath、Valentina Molteni、Shifeng Pan、Jon Loren
    DOI:10.1021/acs.orglett.8b03156
    日期:2018.12.7
    formation of organozinc reagents and subsequent cross-coupling with aryl halides and activated carboxylic acids is reported. Formation of organozinc reagents is achieved by pumping organic halides, in the presence of ZnCl2 and LiCl, through an activated Mg-packed column under flow conditions. This method provides efficient in situ formation of aryl, primary, secondary, and tertiary alkyl organozinc reagents
    报道了一种通用的流动合成方法,用于原位形成有机锌试剂,然后与芳基卤化物和活化的羧酸进行交叉偶联。有机锌试剂的形成是通过在流动条件下将有机卤化物在ZnCl 2和LiCl的存在下泵送通过活化的Mg填充柱来实现的。该方法可有效地原位形成芳基,伯,仲和叔烷基有机锌试剂,随后将其在下游进行Negishi或脱羧Negishi交叉偶联反应的伸缩。所描述的方法提供了使用有机锌试剂获得各种C–C键的方法,这些试剂否则在商业上是不可用的,或者在传统的间歇反应条件下难以制备。
  • Further reactions of t-butyl 3-oxobutanthioate and t-butyl 4-diethyl-phosphono-3-oxobutanthioate : Carbonyl coupling reactions, amination, use in the preparation of 3-acyltetramic acids and application to the total synthesis of fuligorubin A.
    作者:Steven V. Ley、Stephen C. Smith、Peter R. Woodward
    DOI:10.1016/s0040-4020(01)88210-7
    日期:1992.1
    for the preparation of homologated derivatives suitable for amination in the presence of silver (I) trifluoroacetate to afford the corresponding β-ketoamides is discussed. In particular Wadsworth-Emmons coupling reactions of (2) with various carbonyl compounds gave good yields of E-substituted products. Many of the β-ketoamides were shown to be suitable precursors for 3-acyltetramic acids using a Dieckmann
    3-氧代丁氧硫醇叔丁酯(1)和4-二乙基氧代-3-氧杂丁硫醇叔丁酯(2)的制备适合于在三氟乙酸银(I)存在下进行胺化的同系化衍生物,得到相应的β讨论了β-酮酰胺。特别地,(2)与各种羰基化合物的Wadsworth-Emmons偶联反应给出了良好的E-取代产物收率。使用Dieckmann环化反应,以四正丁基氟化铵为环化碱,发现许多β-酮酰胺是3-酰基四酸的合适前体。这些新的反应应用于多烯3-酰基四酸富叶红素A的全合成。
  • Initial Efforts toward the Optimization of Arylomycins for Antibiotic Activity
    作者:Tucker C. Roberts、Mark A. Schallenberger、Jian Liu、Peter A. Smith、Floyd E. Romesberg
    DOI:10.1021/jm1016126
    日期:2011.7.28
    the arylomycin natural product antibiotics, which act via the novel mechanism of inhibiting type I signal peptidase, is broader than previously believed and that resistance in several key human pathogens is due to the presence of a specific Pro residue in the target peptidase that disrupts interactions with the lipopeptide tail of the antibiotic. To begin to test whether this natural resistance might
    虽然大多数临床使用的抗生素来自天然产物,但新的广谱天然产物的分离变得越来越罕见,而且由于其支架或靶标的内在限制,通常认为窄谱药物不适合开发。然而,天然产物抗生素的谱可能会受到某些细菌特定耐药机制的限制,例如靶点突变,并且这种“潜在”抗生素的谱可能会通过衍生化重新优化,就像之前所做的那样临床部署的抗生素。我们最近展示了 arylomycin 天然产物抗生素的谱系,它们通过抑制 I 型信号肽酶的新机制起作用,比以前认为的更广泛,并且几种关键人类病原体的耐药性是由于目标肽酶中存在特定的 Pro 残基,该残基破坏了与抗生素脂肽尾部的相互作用。为了开始测试这种天然抗性是否可以通过衍生化来克服,我们合成了脂肽尾部改变的类似物,并确定了几种具有增加的抗金黄色葡萄球菌。数据支持了芳霉素是潜在抗生素的假设,表明它们的谱可以通过衍生化进行优化,并确定了未来优化工作可能会关注的有前途的支架。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物